Skip to main
  1. Stocks
  2. Faeth Therapeutics Inc
  3. P/E Ratio
FTH

FTH P/E Ratio

P/E Ratio as of Nov 4, 2026: -0.14

Average-0.1487
Median-0.1400
Minimum-0.1900
Maximum-0.1200
-0.14
0.06 (30.00%)past month
The P/E ratio for FTH is -0.14 as of Nov 4, 2026. This represents a decrease of -78.13% compared to its 12-month average P/E ratio of -0.64. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Faeth Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Faeth Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Faeth Therapeutics Inc to industry peers.

FTH P/E Ratio Insights

See Faeth Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in FTH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FTH P/E Ratio Historic Data

DateStock priceP/E ratio
Nov 2, 2026$19.23-0.14
Oct 1, 2026$28.27-0.20
Sep 1, 2026$34.51-0.24
Aug 3, 2026$27.34-0.19
Jul 1, 2026$23.66-0.17
Jun 1, 2026$19.79-1.03
May 1, 2026$26.96-1.41
Apr 1, 2026$34.79-1.63
Mar 2, 2026$29.81-1.40
Feb 2, 2026$9.16-0.43
Jan 2, 2026$9.645-0.45

FTH End of Year P/E Ratio

DateP/E ratioChange
2026-0.14-72.00%
2025-0.50+21.95%
2024-0.41-22.64%
2023-0.53-47.00%
2022-1.00-79.25%
2021-4.82—

FAQs About Faeth Therapeutics Inc (FTH) P/E ratio

The latest P/E ratio of FTH is -0.14, as of Nov 4, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Faeth Therapeutics Inc’s last 12-month average P/E ratio is -0.64, compared to its current P/E ratio of -0.14. This reflects a decrease of -78.13%.

Faeth Therapeutics Inc’s current P/E ratio of -0.14 is lower than its last 12-month average P/E of -0.64. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Faeth Therapeutics Inc’s average P/E ratio over the last 3 years is -0.55. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Faeth Therapeutics Inc’s average P/E ratio over the last 5 years is -0.99. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Faeth Therapeutics Inc (FTH)


FTH P/E Ratio Insights

See Faeth Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in FTH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover FTH stock data and trends